The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1999;341(6):460.

Correspondence
PreviousPrevious
Volume 340:1114-1115 April 8, 1999 Number 14
NextNext

Informed Consent and Approval by Institutional Review Boards in Published Reports on Clinical Trials

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
To the Editor: Publication of the results of biomedical research is not a mere formality in science. It is the culmination of a long process, and careful attention to every step in that process is important.1 In randomized clinical trials, failing to obtain or forgetting to report informed consent from participants or approval of the protocol by an institutional review board (IRB) might suggest that the authors considered these steps unimportant details, if not obstacles. This is clearly a misconception, because the aim of research is to serve human subjects, not to use them.

We assessed the frequency of reporting . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.